With Chen and Stroucken departing, Baxter's board shrinks from 12 to 10 people. Baxter spokeswoman Lauren Russ declined to comment on whether the company intends to replace the two departing board members or provide any further information on the leadership changes. Morningstar analyst Julie Utterback told Crain's in a statement that the retirements aren't unusual, adding that it's possible Baxter replaces the two departing board members later this year.